X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (114) 114
clinical neurology (92) 92
parkinson's disease (62) 62
female (51) 51
male (51) 51
parkinson disease - drug therapy (43) 43
aged (42) 42
middle aged (42) 42
parkinson disease - physiopathology (31) 31
adult (23) 23
antiparkinson agents - therapeutic use (23) 23
index medicus (23) 23
animals (18) 18
levodopa - therapeutic use (17) 17
neurosciences (17) 17
parkinson disease - surgery (17) 17
surgery (16) 16
levodopa - adverse effects (15) 15
treatment outcome (14) 14
basal ganglia (13) 13
parkinson disease - therapy (13) 13
antiparkinson agents - adverse effects (12) 12
globus pallidus - surgery (12) 12
parkinson disease - complications (12) 12
pharmacology & pharmacy (12) 12
dopamine - metabolism (11) 11
dopamine agonists (11) 11
dyskinesias (11) 11
motor complications (11) 11
neurology (11) 11
pallidotomy (11) 11
quality of life (11) 11
subthalamic nucleus (11) 11
double-blind (10) 10
levodopa (10) 10
parkinson disease (10) 10
parkinson disease - diagnosis (10) 10
quality-of-life (10) 10
aged, 80 and over (9) 9
motor fluctuations (9) 9
pramipexole (9) 9
assessment (8) 8
deep brain stimulation (8) 8
levodopa - administration & dosage (8) 8
severity of illness index (8) 8
antiparkinson agents - administration & dosage (7) 7
carbidopa - therapeutic use (7) 7
diagnosis, differential (7) 7
disease progression (7) 7
dopamine agonists - therapeutic use (7) 7
dyskinesia, drug-induced - etiology (7) 7
dystonia (7) 7
l-dopa (7) 7
levodopa-induced dyskinesias (7) 7
neuroprotection (7) 7
parkinson disease - pathology (7) 7
psychiatry (7) 7
ropinirole (7) 7
therapy (7) 7
time factors (7) 7
brain (6) 6
dopa (6) 6
dopamine (6) 6
dose-response relationship, drug (6) 6
drug therapy, combination (6) 6
magnetic resonance imaging (6) 6
movement disorders - etiology (6) 6
neurons (6) 6
neuroprotective agents - therapeutic use (6) 6
parkinson disease - etiology (6) 6
parkinson disease - psychology (6) 6
parkinsons-disease (6) 6
parkinson’s disease (6) 6
progression (6) 6
surveys and questionnaires (6) 6
adolescent (5) 5
animal models (5) 5
antiparkinson agents - pharmacology (5) 5
carbidopa - administration & dosage (5) 5
care and treatment (5) 5
controlled-trial (5) 5
cross-sectional studies (5) 5
dyskinesia, drug-induced - physiopathology (5) 5
follow-up (5) 5
globus pallidus - physiopathology (5) 5
medicine, general & internal (5) 5
parkinson disease - genetics (5) 5
pet (5) 5
risk factors (5) 5
thalamus - surgery (5) 5
tomography, emission-computed (5) 5
age of onset (4) 4
apomorphine (4) 4
biomarkers (4) 4
bromocriptine (4) 4
cerebral stimulation (4) 4
corpus striatum - metabolism (4) 4
delayed-action preparations (4) 4
dementia (4) 4
disease (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Parkinsonism and Related Disorders, ISSN 1353-8020, 2009, Volume 15, Issue 6, pp. 401 - 405
Journal Article
European Journal of Neurology, ISSN 1351-5101, 07/2007, Volume 14, Issue 7, pp. 721 - 728
Pathological studies have prompted the idea that Parkinson disease (PD) is a multisystem disorder, which starts far away from the nigrostriatal dopamine system... 
synucleinopathy | Parkinson disease | Parkinson disease complex | classical Parkinson disease | variability | Classical Parkinson disease | Synucleinopathy | Variability | OLFACTORY DYSFUNCTION | FOLLOW-UP | BRAIN PATHOLOGY | SUBSTANTIA-NIGRA | NEUROSCIENCES | DEFICIENCY | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | ALPHA-SYNUCLEIN PATHOLOGY | LEWY BODIES | PROGRESSION | PET | Parkinson Disease - therapy | Substantia Nigra - pathology | Humans | Cerebral Cortex - pathology | Ubiquitin - metabolism | Male | Risk | Substantia Nigra - metabolism | Corpus Striatum - metabolism | REM Sleep Behavior Disorder - classification | Vagus Nerve - pathology | Cell Death | Medulla Oblongata - pathology | Lewy Bodies - metabolism | Corpus Striatum - pathology | Lewy Body Disease - classification | Dopamine - metabolism | Neurodegenerative Diseases - classification | Enteric Nervous System - pathology | Parkinson Disease - pathology | Neurodegenerative Diseases - pathology | Lewy Body Disease - pathology | Neurodegenerative Diseases - metabolism | Disease Progression | Brain - pathology | Aged | Brain Chemistry | Models, Neurological | Parkinson Disease - classification | Proteasome Endopeptidase Complex - metabolism | Olfaction Disorders - etiology | alpha-Synuclein - metabolism | Parkinson Disease - etiology | Parkinson's disease
Journal Article
Brain, ISSN 0006-8950, 2015, Volume 138, Issue 9, pp. 2701 - 2715
Journal Article
Movement Disorders, ISSN 0885-3185, 01/2010, Volume 25, Issue 1, pp. 122 - 123
Journal Article
Journal Article
Journal Article
Clinical Neuropharmacology, ISSN 0362-5664, 02/2009, Volume 32, Issue 1, pp. 22 - 27
Four to 10% of patients with Parkinson disease and chronically treated with levodopa undergo an addictionlike behavioral disturbance named dopamine... 
Journal Article
Brain, ISSN 0006-8950, 07/2006, Volume 129, Issue 7, p. E48
Journal Article
Clinical Neuropharmacology, ISSN 0362-5664, 02/2008, Volume 31, Issue 1, pp. 19 - 24
Background: Cabergoline is an ergotic dopamine agonist with D2 receptor activity and a very long half-life. This pharmacological profile may result in... 
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2007, Volume 13, pp. S85 - S85
Journal Article